Total Payments
$61,305
2024 Payments
$1,069
Companies
36
Transactions
277
Medicare Patients
1,357
Medicare Billing
$384,446
Payment Breakdown by Category
Other$45,705 (74.6%)
Food & Beverage$11,814 (19.3%)
Travel$3,512 (5.7%)
Education$274.67 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $45,705 | 17 | 74.6% |
| Food and Beverage | $11,814 | 219 | 19.3% |
| Travel and Lodging | $3,512 | 29 | 5.7% |
| Education | $274.67 | 12 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $52,524 | 90 | $0 (2020) |
| Bayer Healthcare Pharmaceuticals Inc. | $977.32 | 23 | $0 (2024) |
| Amgen Inc. | $722.40 | 19 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $651.80 | 12 | $0 (2023) |
| Fresenius USA Marketing, Inc. | $620.34 | 6 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $595.02 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $549.03 | 9 | $0 (2023) |
| AKEBIA THERAPEUTICS INC | $532.14 | 21 | $0 (2024) |
| Relypsa, Inc. | $504.24 | 13 | $0 (2020) |
| Ardelyx, Inc. | $384.64 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,069 | 22 | Ardelyx, Inc. ($351.83) |
| 2023 | $971.27 | 18 | Bayer Healthcare Pharmaceuticals Inc. ($297.62) |
| 2022 | $1,027 | 33 | Bayer HealthCare Pharmaceuticals Inc. ($574.08) |
| 2021 | $725.03 | 21 | AKEBIA THERAPEUTICS INC ($292.09) |
| 2020 | $5,331 | 19 | Amarin Pharma Inc. ($5,129) |
| 2019 | $17,829 | 59 | Amarin Pharma Inc. ($15,959) |
| 2018 | $17,246 | 46 | Amarin Pharma Inc. ($16,139) |
| 2017 | $17,107 | 59 | Amarin Pharma Inc. ($15,296) |
All Payment Transactions
277 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/06/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Nephrology | ||||||
| 10/16/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $123.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/30/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $34.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/29/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/29/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $4.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Cardio-renal | ||||||
| 07/18/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $34.49 | General |
| Category: Diabetes | ||||||
| 06/25/2024 | Ardelyx, Inc. | XPHOZAH 30 MG (Drug) | Food and Beverage | In-kind items and services | $139.48 | General |
| Category: NEPHROLOGY | ||||||
| 06/25/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/20/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $38.17 | General |
| Category: IMMUNOLOGY | ||||||
| 06/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $140.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/16/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Hyperkalemia | ||||||
| 05/07/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: Hyperkalemia | ||||||
| 04/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $34.96 | General |
| Category: Cardio-renal | ||||||
| 04/18/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: NEPHROLOGY | ||||||
| 03/05/2024 | Ardelyx, Inc. | XPHOZAH 30 MG (Drug) | Food and Beverage | In-kind items and services | $119.51 | General |
| Category: NEPHROLOGY | ||||||
| 02/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Cardio-renal | ||||||
| 02/06/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $34.44 | General |
| 12/12/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $120.28 | General |
| Category: DIABETES | ||||||
| 12/06/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $32.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 239 | 1,148 | $160,619 | $99,480 |
| 2022 | 10 | 286 | 1,371 | $166,428 | $89,751 |
| 2021 | 10 | 360 | 1,635 | $190,075 | $102,555 |
| 2020 | 9 | 472 | 2,130 | $184,362 | $92,661 |
Total Patients
1,357
Total Services
6,284
Medicare Billing
$384,446
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 16 | 125 | $62,500 | $37,208 | 59.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 56 | 580 | $48,584 | $36,388 | 74.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 57 | 80 | $20,000 | $8,707 | 43.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 112 | $13,440 | $8,697 | 64.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 36 | 54 | $5,340 | $3,672 | 68.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $4,500 | $2,575 | 57.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 179 | $6,255 | $2,232 | 35.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 17 | 115 | $57,500 | $35,414 | 61.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 67 | 736 | $51,520 | $24,029 | 46.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 71 | 95 | $23,700 | $10,877 | 45.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 135 | $16,115 | $10,419 | 64.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 16 | 186 | $6,893 | $2,357 | 34.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 11 | 37 | $3,700 | $2,287 | 61.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $3,250 | $1,889 | 58.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 24 | 30 | $2,910 | $1,829 | 62.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $420.00 | $397.08 | 94.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 12 | 12 | $420.00 | $253.08 | 60.3% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 16 | 105 | $52,500 | $32,748 | 62.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 100 | 898 | $62,990 | $29,454 | 46.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 99 | 125 | $31,250 | $14,528 | 46.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 46 | 149 | $17,540 | $11,506 | 65.6% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 17 | 103 | $10,300 | $6,446 | 62.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $4,500 | $2,661 | 59.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 31 | 42 | $4,170 | $2,610 | 62.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 11 | 173 | $6,055 | $2,164 | 35.7% |
About Dr. Peter Lee, M.D
Dr. Peter Lee, M.D is a Nephrology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1932237013.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Lee, M.D has received a total of $61,305 in payments from pharmaceutical and medical device companies, with $1,069 received in 2024. These payments were reported across 277 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($45,705).
As a Medicare-enrolled provider, Lee has provided services to 1,357 Medicare beneficiaries, totaling 6,284 services with total Medicare billing of $384,446. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Los Angeles, CA
- Active Since 03/01/2007
- Last Updated 07/09/2007
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1932237013
Products in Payments
- Vascepa (Drug) $52,524
- Kerendia (Drug) $977.32
- Veltassa (Drug) $805.37
- Velphoro (Drug) $620.34
- Auryxia (Drug) $611.89
- SAMSCA (Drug) $496.90
- Parsabiv (Biological) $449.67
- LOKELMA (Drug) $392.35
- ACTHAR (Biological) $381.32
- JARDIANCE (Drug) $328.51
- XPHOZAH 30 MG (Drug) $258.99
- TOUJEO (Drug) $257.30
- SOLIRIS (Drug) $225.65
- Parsabiv (Drug) $221.47
- KRYSTEXXA (Biological) $180.93
- FARXIGA (Drug) $179.24
- JYNARQUE (Drug) $154.90
- Renal - Non Product Related (Biological) $130.96
- IBSRELA (Drug) $125.65
- SPIRIVA RESPIMAT (Drug) $124.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Los Angeles
Anjay Rastogi, Md, MD
Nephrology — Payments: $2.5M
Nephrology $2.5M
Dr. Suphamai Bunnapradist, M.d, M.D
Nephrology — Payments: $462,290
Nephrology $462,290
Dr. Tariq Shah, M.d, M.D
Nephrology — Payments: $342,153
Nephrology $342,153
Victoria Kumar, Md, MD
Nephrology — Payments: $319,042
Nephrology $319,042
Victor Carabello, M.d, M.D
Nephrology — Payments: $277,340
Nephrology $277,340
Susanne Nicholas, Md, MD
Nephrology — Payments: $142,466
Nephrology $142,466